Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy
L. Balducci et Gh. Lyman, Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy, J CL ONCOL, 19(5), 2001, pp. 1583-1584